Risk factors for contrast-induced nephropathy

Kidney and Blood Pressure Research

Volumn 29, Issue 2, 2006, Pages 84-93

  Toprak, Omer ^a,b   Cirit, Mustafa ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast media, nephropathy; Contrast induced nephropathy; Coronary angiography, contrast induced nephropathy; Risk factors, contrast induced nephropathy

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; AMPHOTERICIN B; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CISPLATIN; CONTRAST MEDIUM; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ECHO CONTRAST MEDIUM; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; GADOLINIUM CHELATE; INSULIN; IODINATED CONTRAST MEDIUM; IONIC CONTRAST MEDIUM; LOOP DIURETIC AGENT; MANNITOL; METFORMIN; NONIONIC CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E1; SODIUM CHLORIDE; SULFONAMIDE; UNINDEXED DRUG;

ACUTE HEART INFARCTION; ANEMIA; ANGIOPLASTY; CHRONIC KIDNEY FAILURE; CLINICAL RESEARCH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG CLEARANCE; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HOSPITAL COST; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOALBUMINEMIA; HYPOTENSION; HYPOVOLEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INTERVENTION STUDY; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER CIRRHOSIS; LOW DRUG DOSE; LUNG EDEMA; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SEPSIS;

AGED; CONTRAST MEDIA; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 33747047244     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093381     Document Type: Review

References (76)

1. McCullough PA, Soman SS: Contrast-induced nephropathy. Crit Care Clin 2005;21:261-280.
2. Gleeson TG, Bulugahapitiya S: Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673-1689.
3. Gami AS, Garovic VD: Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004;79:211-219.
4. Lepor NE: Radiocontrast nephropathy: the dye is not cast. Rev Cardiovasc Med 2000;1:43-54.
5. Itoh Y, Yano T, Sendo T, et al: Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005;97:473-488.
6. Morcos SK, Thomsen HS; European Society of Urogenital Radiology: European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003;28:187-190.
7. McDougal WS: Early detection of acute renal failure by serum cystatin C. J Urol 2005;174:1024-1025.
8. Artunc FH, Fischer IU, Risler T, et al: Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol 2005;102:173-178.
9. Rich MW, Crecelius CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990;150:1237-1242.
10. Rihal CS, Textor SC, Grill DE, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
11. Persson PB, Hansell P, Liss P: Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22.
12. Goldenberg I, Matetzky S: Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172:1461-1471.
13. Detrenis S, Meschi M, Musini S, et al: Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 2005;20:1542-1550.
14. Heyman SN, Rosenberger C, Rosen S: Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant Suppl 2005;20:6-11.
15. Dangas G, Iakovou I, Nikolsky E, et al: Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19.
16. Marenzi G, Lauri G, Assanelli E, et al: Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-1785.
17. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: a cohort analysis. JAMA1996;275:1489-1494.
18. Maeder M, Klein M, Fehr T, et al: Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004;44:1763-1771.
19. Ide JM, Lancelot E, Pines E, et al: Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Invest Radiol 2004;39:155-170.
20. Lin J, Bonventre JV: Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005;14:105-110.
21. Asif A, Epstein M: Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004;44:12-24.
22. Erley CM, Bader BD, Berger ED, et al: Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 2004;19:2526-2531.
23. Ergun I, Keven K, Uruc I, et al: The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006;21:697-700.
24. Jakobsen JA, Oyen R, Thomsen HS, et al; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR): Safety of ultrasound contrast agents. Eur Radiol 2005;15:941-945.
25. Gomes VO, Poli de Figueredo CE, et al: N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 2005;91:774-778.
26. Toprak O, Cirit M, Bayata S, et al: Review of the radiocontrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg 2004;4:331-335.
27. Mehran R, Aymong ED, Nikolsky E, et al: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-1399.
28. Bartholomew BA, Harjai KJ, Dukkipati S, et al: Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-1519.
29. 2 during water diuresis as evaluated by blood oxygen level-dependent magnetic resonance imaging. Kidney Int 1999;55:294-298.
30. Kohli HS, Bhaskaran MC, Muthukumar T, et al: Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 2000;15:212-217.
31. Kisley LR, Sakai RR, Flanagan-Cato LM, et al: Estrogen increases angiotensin II-induced c-Fos expression in the vasopressinergic neurons of the paraventricular nucleus in the female rat. Neuroendocrinology 2000;72:306-317.
32. Iakovou I, Dangas G, Mehran R, et al: Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003;15:18-22.
33. Rudnick MR, Goldfarb S, Wexler L, et al: Nephrotoxicity of ionic and nonionic contrast media in 1,196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
34. Moore RD, Steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolarity vs low-osmolarity contrast media: randomized clinical trial. Radiology. 1992;182:649-655.
35. Barrett BJ, Parfrey PS, Vavasour HM, et al: Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992;41:1274-1279.
36. McCullough PA, Wolyn R, Rocher LL, et al: Acute renal failure after coronary intervention: incidence, risk factors, and relationships to mortality. Am J Med 1997;103:368-375.
37. Weinrauch LA, Healy RW, Leland OS Jr, et al: Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 1977;86:56-59.
38. Asif A, Preston RA, Roth D: Radiocontrast-induced nephropathy. Am J Ther 2003;10:137-147.
39. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 1991;157:49-58.
40. Parfrey PS, Griffiths SM, Barrett BJ, et al: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989;320:143-149.
41. Gruberg L, Mintz GS, Mehran R, et al: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
42. Schillinger M, Haumer M, Mlekusch W, et al: Predicting renal failure after balloon angioplasty in high-risk patients. J Endovasc Ther 2001;8:609-614.
43. Toprak O, Cirit M, Bayata S, et al: Is there any relationship between left ventricular ejection fraction and contrast induced nephropathy? Turk Klin J Med Sci 2003;23:104-107.
44. Louis BM, Hoch BS, Hernandez C, et al: Protection from the nephrotoxicity of contrast dye. Ren Fail 1996;18:639-646.
45. Caldicott WJ, Hollenberg NK, Abrams HL: Characteristics of response of renal vascular bed to contrast media: evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970;5:539-547.
46. Workman RJ, Shaff MI, Jackson RV, et al: Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983;18:160-166.
47. Gupta RK, Kapoor A, Tewari S, et al: Captopril for preventing of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J 1999;51:521-526.
48. Toprak O, Cirit M, Bayata S, et al: The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg 2003;3:98-103.
49. Cirit M, Toprak O, Yesil M, et al: Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 2006;104:20-27.
50. +-ATPase activity in the inner medullary collecting duct. Am J Physiol 1989; 257(3 Pt 2):F424-F430.
51. Kolonko A, Kokot F, Wiecek A: Contrast-associated nephropathy - old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 1998;13:803-806.
52. Weisbord SD, Palevsky PM: Radiocontrast-induced acute renal failure. J Intensive Care Med 2005;20:63-75.
53. Holland MD, Galla JH, Sanders PW, et al: Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int 1985;27:46-50.
54. McCarthy CS, Becker JA: Multiple myeloma and contrast media. Radiology 1992;183:519-521.
55. Salpeter S, Greyber E, Pasternak G, et al: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2003;2:CD002967.
56. Nawaz S, Cleveland T, Gaines PA, et al: Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 1998;53:342-344.
57. Andrade L, Campos SB, Seguro AC: Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of arginine. Kidney Int 1998;53:1736-1742.
58. Yang DW, Jia RH, Yang DP, et al: Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J 2004; 117:542-546.
59. Postlethwaite AE, Kelley WN: Uricosuric effect of radiocontrast agents: a study in man of four commonly used preparations. Ann Intern Med 1971;74:845-852.
60. Perlstein TS, Gumieniak O, Hopkins PN, et al: Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004;66:1465-1470.
61. Toprak O, Cirit M, Esi E, et al: Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv 2006;67:227-235.
62. Weber-Mzell D, Kotanko P, Schumacher M, et al: Coronary anatomy predicts presence or absence of renal artery stenosis: a prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 2002;23:1684-1691.
63. Dudzinski PJ, Petrone AF, Persoff M, et al: Acute renal failure following high dose excretory urography in dehydrated patients. J Urol 1971;106:619-621.
64. Nygren A, Ulfendahl HR: Effects of high- and low-osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats. Acta Radiol 1989;30:383-389.
65. Katzberg RW: Contrast medium-induced nephrotoxicity: which pathway? Radiology 2005;235:752-725.
66. Toprak O, Cirit M: Investigating the volume status before contrast nephropathy studies. Nephrol Dial Transplant 2005;20:464.
67. Ahuja TS, Niaz N, Agraharkar M: Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol 2000;54:11-14.
68. Sadeghi HM, Stone GW, Grines CL, et al: Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-2775.
69. Nikolsky E, Mehran R, Lasic Z, et al: Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005;67:706-713.
70. Vuong TD, Braam B, Willekes-Koolschijn N, et al: Hypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003;18:1485-1492.
71. Toprak O, Cirit M, Yesil M, et al: Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res 2006;29:2-9.
72. Cigarroa RG, Lange RA, Williams RH, et al: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-652.
73. Soejima K, Uozumi J, Kanou T, et al: Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices. Toxicol Lett 2003;143:17-25.
74. Baker CS, Wragg A, Kuna S, et al: A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID Study. J Am Coll Cardiol 2003;41:2114-2118.
75. Byrd L, Sherman R: Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine (Baltimore) 1979;58:270-279.
76. Gruberg L, Mehran R, Dangas G, et al: Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;52:409-416.